HRS/ACC科学声明:心内导管消融术当日出院指导原则
该科学声明由HRS/ACC发布,分析全球临床数据与真实世界证据(含美国医疗保险与医疗补助服务中心索赔数据),评估心内导管消融当日出院策略对患者安全、就医可及性、运营效率和医疗支出的影响。声明指出,技术进步与流程优化提高了消融效率并降低并发症率,但就医可及性限制加剧,尤其在COVID-19公共卫生紧急状态期间,经济压力推动缩短住院时间。全球临床研究提供概念验证,真实世界证据显示并发症及再入院/急诊就诊发生率低。声明基于共享决策提出推荐最佳实践,并指出随着门诊手术中心等替代治疗场所的发展,真实世界注册登记应追踪结局以指导未来决策。
要点
- 全球临床研究提供概念验证,真实世界证据/美国医疗保险与医疗补助服务中心索赔数据显示心内导管消融当日出院策略下并发症及再入院/急诊就诊发生率低。
- 技术进步与流程策略改进提高了消融手术效率、成功率并降低并发症率,但就医可及性限制加剧,COVID-19公共卫生紧急状态期间尤为突出。
- 声明基于共享决策策略提出推荐最佳实践,以优化患者安全、舒适度和手术结局。
- 随着门诊手术中心等替代治疗场所的发展,真实世界注册登记应追踪结局以指导未来决策。
适用人群与场景
- 接受经皮心内导管消融的介入心脏电生理患者。
处置流程与药物剂量
- 推荐采用共享决策策略制定当日出院计划,以优化患者安全、舒适度和手术结局(声明推荐最佳实践,原文未给出具体推荐等级标签)。
研究设计与关键结果
- 声明分析全球临床数据与真实世界证据(含美国医疗保险与医疗补助服务中心索赔数据),评估当日出院策略对患者安全、就医可及性、运营效率和医疗支出的影响。
- 全球临床研究提供概念验证,真实世界证据/索赔数据显示当日出院策略下并发症及再入院/急诊就诊发生率低。
证据类型、等级与局限
- 证据类型:HRS/ACC科学声明,基于全球临床研究(概念验证)与真实世界证据/美国医疗保险与医疗补助服务中心索赔数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 声明支持将当日出院策略纳入心内导管消融实践,基于共享决策优化患者安全、舒适度和手术结局(作者/声明推荐)。
- 随着门诊手术中心等替代治疗场所的发展,真实世界注册登记应追踪结局以指导未来决策(作者/声明建议)。
指南或共识出处
- HRS/ACC科学声明:心内导管消融术当日出院指导原则(Heart Rhythm)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Percutaneous catheter ablation in interventional cardiac electrophysiology has evolved over the past several decades. Technologic advances and evolving procedural strategies have improved procedural efficiencies, increased success rates, and lowered complication rates. These advances have increased the ability to treat more patients successfully; however, limitations to access have grown. Access challenges (exacerbated during the COVID-19 public health emergency) and economic pressures have driven a shift in practice trends to reduce hospitalization duration and optimize resource utilization. A same-day discharge (SDD) strategy has increasingly been used to address these challenges. Incorporating a SDD strategy has recently been supported by global clinical studies (demonstrating proof of concept) and real-world evidence/United States Centers for Medicare & Medicaid Services claims data (characterizing a low incidence of complications and need for readmission/emergency department visits). This document analyzes available global clinical data and real-world evidence examining the impact of a cardiac ablation SDD strategy on patient safety, patient access, operational efficiencies, and health care expenditures. Recommended best practices will also be characterized built on the foundation of a shared decision-making strategy that optimizes patient safety, comfort, and procedural outcomes. As clinical flow paradigms evolve with alternate sites of care (ie, ambulatory surgery centers), real-world registries to track outcomes should inform future decision-making.
参考来源
- Shanker AJ, Jones SO, Blankenship JC, et al. HRS/ACC scientific statement: Guiding principles on same-day discharge for intracardiac catheter ablation procedures. Heart Rhythm. 2025. PMID: 40272340. doi:10.1016/j.hrthm.2025.02.029
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。